4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-22-014473
President and CEO acquired 65,047 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schultz Kare · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-28 | Exercise or conversion : show line 1 in the form | +65,047 | 1,132,496 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-28 | Exercise or conversion : show line 2 in the form Restricted Share Units | −65,047 | 130,096 | D |
Loading xslF345X03/doc4.xml…